Whipplewood Advisors LLC Takes $29,000 Position in Teladoc Health, Inc. (NYSE:TDOC)

Whipplewood Advisors LLC bought a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the fourth quarter, Holdings Channel.com reports. The fund bought 3,200 shares of the health services provider’s stock, valued at approximately $29,000.

A number of other institutional investors have also made changes to their positions in the business. Versant Capital Management Inc boosted its position in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after purchasing an additional 2,441 shares during the period. Blue Trust Inc. lifted its stake in shares of Teladoc Health by 84.5% during the 3rd quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock worth $40,000 after buying an additional 1,854 shares during the last quarter. KBC Group NV boosted its holdings in shares of Teladoc Health by 72.3% during the 4th quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock worth $80,000 after buying an additional 3,714 shares during the period. Westside Investment Management Inc. grew its stake in Teladoc Health by 43.8% in the 4th quarter. Westside Investment Management Inc. now owns 9,200 shares of the health services provider’s stock valued at $84,000 after buying an additional 2,800 shares during the last quarter. Finally, GSA Capital Partners LLP bought a new position in Teladoc Health in the 3rd quarter valued at about $92,000. 76.82% of the stock is owned by institutional investors and hedge funds.

Teladoc Health Stock Up 0.6 %

NYSE TDOC opened at $9.56 on Friday. The business has a fifty day moving average price of $10.62 and a two-hundred day moving average price of $9.57. The stock has a market capitalization of $1.65 billion, a PE ratio of -1.66 and a beta of 1.05. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.95. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The business had revenue of $640.49 million for the quarter, compared to the consensus estimate of $639.44 million. Equities analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the company. Oppenheimer decreased their target price on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research report on Friday, January 24th. The Goldman Sachs Group upped their price objective on Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a report on Tuesday, February 18th. Bank of America increased their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research report on Wednesday, February 12th. Piper Sandler reduced their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday. Finally, Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $11.44.

Insider Activity

In other news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction on Monday, December 2nd. The stock was sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now directly owns 2,890 shares in the company, valued at approximately $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.95% of the stock is currently owned by corporate insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.